Sfoglia per Autore
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir
2020-03-11 Bouba, Y; Berno, G; Fabeni, L; Carioti, L; Salpini, R; Aquaro, S; Svicher, V; Perno, Cf; Ceccherini-Silberstein, F; Santoro, M
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
2020-04-01 Semengue, Enj; Santoro, M; Ndze, Vn; Dambaya, B; Takou, D; Teto, G; Nka, Ad; Fabeni, L; Wiyeh, A; Ceccherini-Silberstein, F; Colizzi, V; Perno, C; Fokam, J
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
2020-05-01 Fokam, J; Nangmo, A; Wandum, C; Takou, D; Santoro, M; Nlend, An; Ateba, Fn; Ndombo, Pk; Kamgaing, N; Kamta, C; Essiane, A; Lambo, V; Fokunang, C; Mbanya, D; Colizzi, V; Perno, C; Ndjolo, A
Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon
2020-07-01 Fokam, J; Takou, D; Teto, G; Nforbih, Se; Kome, Op; Santoro, M; Ngoufack, Es; Eyongetah, M; Palmer, D; Fokunang, Et; Fokunang, Cn; Colizzi, V; Perno, C-; Ndjolo, A
Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen
2020-07-01 Santoro, M; Fornabaio, C; Malena, M; Galli, L; Poli, A; Menozzi, M; Zazzi, M; White, K; Castagna, A; PRESTIGIO Study, G
Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry
2020-08-01 Canetti, D; Galli, L; Gianotti, N; Celotti, A; Calza, L; Gagliardini, R; Rusconi, S; Modica, S; Cenderello, G; Ferrara, M; Santoro, M; Zazzi, M; Castagna, A
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
2020-08-01 Fokam, J; Takou, D; Semengue, Enj; Teto, G; Beloumou, G; Dambaya, B; Santoro, M; Mossiang, L; Billong, Sc; Cham, F; Sosso, Sm; Temgoua, Es; Nanfack, Aj; Moudourou, S; Kamgaing, N; Kamgaing, R; Ngako Pamen, Jn; Etame, Mmn; Bissek, Az; Elat, Jn; Moussi, Ee; Colizzi, V; Perno, C; Ndjolo, A
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings
2020-09-01 Armenia, D; Bouba, Y; Gagliardini, R; Gori, C; Bertoli, A; Borghi, V; Gennari, W; Micheli, V; Callegaro, Ap; Gazzola, L; Bruzzone, B; Giannetti, A; Mazzotta, V; Vergori, A; Mastrorosa, I; Colafigli, M; Lichtner, M; di Biagio, A; Maggiolo, F; Rizzardini, G; d'Arminio Monforte, A; Andreoni, M; Mussini, C; Antinori, A; Ceccherini Silberstein, F; Perno, Cf; Santoro, M
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients
2020-09-01 Saladini, F; Giannini, A; Giammarino, F; Maggiolo, F; Vichi, F; Corbelli, Gm; Galli, A; Bigoloni, A; Poli, A; Santoro, M; Zazzi, M; Castagna, A
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry
2020-11-01 Galli, L; Parisi, Mr; Poli, A; Menozzi, M; Fiscon, M; Garlassi, E; Francisci, D; Di Biagio, A; Sterrantino, G; Fornabaio, C; Degli Antoni, A; Angarano, G; Fusco, Fm; D'Arminio Monforte, A; Corbelli, Gm; Santoro, M; Zazzi, M; Castagna, A
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b
2021-01-01 Alkhatib, M; DI MAIO, Vc; De Murtas, V; Polilli, E; Milana, M; Teti, E; Fiorentino, G; Calvaruso, V; Barbaliscia, S; Bertoli, A; Scutari, R; Carioti, L; Cento, V; Santoro, M; Orro, A; Maida, I; Lenci, I; Sarmati, L; Craxì, A; Pasquazzi, C; Parruti, G; Babudieri, S; Milanesi, L; Andreoni, M; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F; Svicher, V; Salpini, R
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga
2021-01-01 Mortari, Ep; Russo, C; Vinci, Mr; Terreri, S; Salinas, Af; Piccioni, L; Alteri, C; Colagrossi, L; Coltella, L; Ranno, S; Linardos, G; Agosta, M; Albano, C; Agrati, C; Castilletti, C; Meschi, S; Romania, P; Roscilli, G; Pavoni, E; Camisa, V; Santoro, A; Brugaletta, R; Magnavita, N; Ruggiero, A; Cotugno, N; Amodio, D; Atti, Mlcd; Giorgio, D; Russo, N; Salvatori, G; Corsetti, T; Locatelli, F; Perno, Cf; Zaffina, S; Carsetti, R
Prevalence and factors associated with HIV-1 multidrug resistance over the past two decades in the Italian Arca database
2021-01-01 Lombardi, F; Giacomelli, A; Armenia, D; Lai, A; Dusina, A; Bezench, A; Timelli, L; Saladini, F; Vichi, F; Corsi, P; Colao, G; Bruzzone, B; Gagliardini, R; Callegaro, A; Castagna, A; Santoro, M; Group., Ftas
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings
2021-04-13 Semengue, Enj; Armenia, D; Inzaule, S; Santoro, M; Dambaya, B; Takou, D; Teto, G; Nka, Ad; Yagai, B; Fabeni, L; Chenwi, C; Angong Beloumou, G; Djupsa Ndjeyep, Sc; Colizzi, V; Perno, C; Ceccherini-Silberstein, F; Fokam, J
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice
2021-07-01 Armenia, D; Bouba, Y; Gagliardini, R; Fabeni, L; Borghi, V; Berno, G; Vergori, A; Cicalini, S; Mussini, C; Antinori, A; Ceccherini Silberstein, F; Perno, Cf; Santoro, M
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy
2021-07-01 Lai, A; Franzetti, M; Bergna, A; Saladini, F; Bruzzone, B; Di Giambenedetto, S; Di Biagio, A; Lo Caputo, S; Santoro, M; Maggiolo, F; Parisi, Sg; Rusconi, S; Gianotti, N; Balotta, C
HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: a systematic review and meta-analysis protocol
2021-07-01 Nka, Ad; Teto, G; Santoro, M; Ngum Ndze, V; Takou, D; Dambaya, B; Ngoufack Jagni Semengue, E; Fabeni, L; Perno, C; Colizzi, V; Ceccherini Silberstein, F; Fokam, J
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study
2021-07-19 Scutari, R; Costabile, V; Galli, L; Bellocchi, Mc; Carioti, L; Barbaliscia, S; Poli, A; Galli, A; Perno, Cf; Santoro, M; Castagna, A; Ceccherini Silberstein, F; Alteri, C; Spagnuolo, V
Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon
2021-08-01 Fokam, J; Takou, D; Njume, D; Pabo, W; Santoro, M; Njom Nlend, A; Beloumou, G; Sosso, S; Moudourou, S; Teto, G; Dambaya, B; Djupsa, S; Tetang Ndiang, S; Ateba, Fn; Billong, Sc; Kamta, C; Bala, L; Lambo, V; Tala, V; Chenwi Ambe, C; Mpouel, Ml; Cappelli, G; Cham, F; Ndip, R; Mbuagbaw, L; Koki Ndombo, P; Ceccherini Silberstein, F; Colizzi, V; Perno, C; Ndjolo, A
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease
2021-09-16 Bouba, Y; Armenia, D; Forbici, F; Bertoli, A; Borghi, V; Gagliardini, R; Vergori, A; Cicalini, S; Mazzotta, V; Malagnino, V; Lichtner, M; Latini, A; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Ceccherini Silberstein, F; Santoro, M
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
11-mar-2020 | Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir | Bouba, Y; Berno, G; Fabeni, L; Carioti, L; Salpini, R; Aquaro, S; Svicher, V; Perno, Cf; Ceccherini-Silberstein, F; Santoro, M | Articolo su rivista | |
1-apr-2020 | HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol | Semengue, Enj; Santoro, M; Ndze, Vn; Dambaya, B; Takou, D; Teto, G; Nka, Ad; Fabeni, L; Wiyeh, A; Ceccherini-Silberstein, F; Colizzi, V; Perno, C; Fokam, J | Articolo su rivista | |
1-mag-2020 | Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon | Fokam, J; Nangmo, A; Wandum, C; Takou, D; Santoro, M; Nlend, An; Ateba, Fn; Ndombo, Pk; Kamgaing, N; Kamta, C; Essiane, A; Lambo, V; Fokunang, C; Mbanya, D; Colizzi, V; Perno, C; Ndjolo, A | Articolo su rivista | |
1-lug-2020 | Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon | Fokam, J; Takou, D; Teto, G; Nforbih, Se; Kome, Op; Santoro, M; Ngoufack, Es; Eyongetah, M; Palmer, D; Fokunang, Et; Fokunang, Cn; Colizzi, V; Perno, C-; Ndjolo, A | Articolo su rivista | |
1-lug-2020 | Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen | Santoro, M; Fornabaio, C; Malena, M; Galli, L; Poli, A; Menozzi, M; Zazzi, M; White, K; Castagna, A; PRESTIGIO Study, G | Articolo su rivista | |
1-ago-2020 | Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry | Canetti, D; Galli, L; Gianotti, N; Celotti, A; Calza, L; Gagliardini, R; Rusconi, S; Modica, S; Cenderello, G; Ferrara, M; Santoro, M; Zazzi, M; Castagna, A | Articolo su rivista | |
1-ago-2020 | First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens | Fokam, J; Takou, D; Semengue, Enj; Teto, G; Beloumou, G; Dambaya, B; Santoro, M; Mossiang, L; Billong, Sc; Cham, F; Sosso, Sm; Temgoua, Es; Nanfack, Aj; Moudourou, S; Kamgaing, N; Kamgaing, R; Ngako Pamen, Jn; Etame, Mmn; Bissek, Az; Elat, Jn; Moussi, Ee; Colizzi, V; Perno, C; Ndjolo, A | Articolo su rivista | |
1-set-2020 | Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings | Armenia, D; Bouba, Y; Gagliardini, R; Gori, C; Bertoli, A; Borghi, V; Gennari, W; Micheli, V; Callegaro, Ap; Gazzola, L; Bruzzone, B; Giannetti, A; Mazzotta, V; Vergori, A; Mastrorosa, I; Colafigli, M; Lichtner, M; di Biagio, A; Maggiolo, F; Rizzardini, G; d'Arminio Monforte, A; Andreoni, M; Mussini, C; Antinori, A; Ceccherini Silberstein, F; Perno, Cf; Santoro, M | Articolo su rivista | |
1-set-2020 | In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients | Saladini, F; Giannini, A; Giammarino, F; Maggiolo, F; Vichi, F; Corbelli, Gm; Galli, A; Bigoloni, A; Poli, A; Santoro, M; Zazzi, M; Castagna, A | Articolo su rivista | |
1-nov-2020 | Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry | Galli, L; Parisi, Mr; Poli, A; Menozzi, M; Fiscon, M; Garlassi, E; Francisci, D; Di Biagio, A; Sterrantino, G; Fornabaio, C; Degli Antoni, A; Angarano, G; Fusco, Fm; D'Arminio Monforte, A; Corbelli, Gm; Santoro, M; Zazzi, M; Castagna, A | Articolo su rivista | |
1-gen-2021 | Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b | Alkhatib, M; DI MAIO, Vc; De Murtas, V; Polilli, E; Milana, M; Teti, E; Fiorentino, G; Calvaruso, V; Barbaliscia, S; Bertoli, A; Scutari, R; Carioti, L; Cento, V; Santoro, M; Orro, A; Maida, I; Lenci, I; Sarmati, L; Craxì, A; Pasquazzi, C; Parruti, G; Babudieri, S; Milanesi, L; Andreoni, M; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F; Svicher, V; Salpini, R | Articolo su rivista | |
1-gen-2021 | Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga | Mortari, Ep; Russo, C; Vinci, Mr; Terreri, S; Salinas, Af; Piccioni, L; Alteri, C; Colagrossi, L; Coltella, L; Ranno, S; Linardos, G; Agosta, M; Albano, C; Agrati, C; Castilletti, C; Meschi, S; Romania, P; Roscilli, G; Pavoni, E; Camisa, V; Santoro, A; Brugaletta, R; Magnavita, N; Ruggiero, A; Cotugno, N; Amodio, D; Atti, Mlcd; Giorgio, D; Russo, N; Salvatori, G; Corsetti, T; Locatelli, F; Perno, Cf; Zaffina, S; Carsetti, R | Articolo su rivista | |
1-gen-2021 | Prevalence and factors associated with HIV-1 multidrug resistance over the past two decades in the Italian Arca database | Lombardi, F; Giacomelli, A; Armenia, D; Lai, A; Dusina, A; Bezench, A; Timelli, L; Saladini, F; Vichi, F; Corsi, P; Colao, G; Bruzzone, B; Gagliardini, R; Callegaro, A; Castagna, A; Santoro, M; Group., Ftas | Articolo su rivista | |
13-apr-2021 | Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings | Semengue, Enj; Armenia, D; Inzaule, S; Santoro, M; Dambaya, B; Takou, D; Teto, G; Nka, Ad; Yagai, B; Fabeni, L; Chenwi, C; Angong Beloumou, G; Djupsa Ndjeyep, Sc; Colizzi, V; Perno, C; Ceccherini-Silberstein, F; Fokam, J | Articolo su rivista | |
1-lug-2021 | Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice | Armenia, D; Bouba, Y; Gagliardini, R; Fabeni, L; Borghi, V; Berno, G; Vergori, A; Cicalini, S; Mussini, C; Antinori, A; Ceccherini Silberstein, F; Perno, Cf; Santoro, M | Articolo su rivista | |
1-lug-2021 | Marked decrease in acquired resistance to antiretrovirals in latest years in Italy | Lai, A; Franzetti, M; Bergna, A; Saladini, F; Bruzzone, B; Di Giambenedetto, S; Di Biagio, A; Lo Caputo, S; Santoro, M; Maggiolo, F; Parisi, Sg; Rusconi, S; Gianotti, N; Balotta, C | Articolo su rivista | |
1-lug-2021 | HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: a systematic review and meta-analysis protocol | Nka, Ad; Teto, G; Santoro, M; Ngum Ndze, V; Takou, D; Dambaya, B; Ngoufack Jagni Semengue, E; Fabeni, L; Perno, C; Colizzi, V; Ceccherini Silberstein, F; Fokam, J | Articolo su rivista | |
19-lug-2021 | Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study | Scutari, R; Costabile, V; Galli, L; Bellocchi, Mc; Carioti, L; Barbaliscia, S; Poli, A; Galli, A; Perno, Cf; Santoro, M; Castagna, A; Ceccherini Silberstein, F; Alteri, C; Spagnuolo, V | Articolo su rivista | |
1-ago-2021 | Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon | Fokam, J; Takou, D; Njume, D; Pabo, W; Santoro, M; Njom Nlend, A; Beloumou, G; Sosso, S; Moudourou, S; Teto, G; Dambaya, B; Djupsa, S; Tetang Ndiang, S; Ateba, Fn; Billong, Sc; Kamta, C; Bala, L; Lambo, V; Tala, V; Chenwi Ambe, C; Mpouel, Ml; Cappelli, G; Cham, F; Ndip, R; Mbuagbaw, L; Koki Ndombo, P; Ceccherini Silberstein, F; Colizzi, V; Perno, C; Ndjolo, A | Articolo su rivista | |
16-set-2021 | Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease | Bouba, Y; Armenia, D; Forbici, F; Bertoli, A; Borghi, V; Gagliardini, R; Vergori, A; Cicalini, S; Mazzotta, V; Malagnino, V; Lichtner, M; Latini, A; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Ceccherini Silberstein, F; Santoro, M | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile